-
Combined Lenvatinib and Pembrolizumab As Salvage Therapy in Advanced Adrenal Cortical Carcinoma
Journal of Immunotherapy of Cancer, 2020
-
Pembrolizumab Alone or With Chemotherapy Versus Cetuximab With Chemotherapy for Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (KEYNOTE-048): A Randomised, Open-Label, Phase 3 Study
Lancet, 2019
-
Phase 3 Study of Pembrolizumab Plus Chemoradiation (CRT) vs CRT Alone for Locally Advanced Head and Neck Squamous Cell Carcinoma (LA-HNSCC)
Society for Immunotherapy of Cancer (SITC) 2017 Conference, 2017
-
An Interprofessionally Developed Geriatric Oncology Curriculum for Hematology-Oncology Fellows
Journal of Geriatric Oncology, 2015
-
A Case of Vemurafenib-Induced Sweet’s Syndrome
The Journal of Dermatology, 2014
-
Treatment Decisions in a Man with Hodgkin Lymphoma and Guillian-Barre Syndrome: A Case Report
Journal of Medical Case Reports, 2014
-
Influence of Medical Comorbidities on the Presentation and Outcomes of Stage I-III Non-Small Cell Lung Cancer
Clinical Lung Cancer, 2013
-
Rare Though Not Mutually Exclusive: a Report of Three Cases of Concomitant Kras and Braf Mutation and a Review of the Literature
Journal of Cancer, 2013
-
Toxicities and Outcomes in Metastatic Melanoma Patients Treated with Ipilimumab and Braf Inhibitors
Society for Melanoma Research 2013 Congress, 2013
-
Improving the Care of Acute Lymphocytic Leukemia (ALL) at a Large County Hospital
American Society of Clinical Oncology Quality Care Symposium, 2013
-
Assessment of Absolute Lymphocyte Count (ALC) as a Predictor of Progression-Free Survival (PFS) and Overall Response Rate (ORR) in Metastatic Melanoma (MM) Patients (PTS) Treated with High-Dose Interleukin-2 (HD Il-2)
American Society of Clinical Oncology National Meeting, 2013
-
Assessment of Absolute Lymphocyte Count (ALC) as a Predictor of Progression-Free Survival (PFS) and Overall Response Rate (ORR) in Metastatic Melanoma (MM) Patients (PTS) Treated with High-Dose Interleukin-2 (HD Il-2)
ASCO Annual Meeting, 2013
-
How Have We Diagnosed Early-Stage Lung Cancer Without Radiographic Screening? A Contemporary Single-Center Experience
PLoS ONE, 2012
-
Socioeconomic Disparities in Lung Cancer Treatment and Outcomes Persist Within a Single Academic Medical Center
Clinical Lung Cancer, 2012
-
Recent Advances and Emerging Therapies in the Systemic Treatment of Metastatic Melanoma
Clinical Oncology News, 2012
-
A Primer on the Current State-of-the-Science Neoadjuvant and Adjuvant Therapy for Patients with Locally Advanced Rectal Adenocarcinomas
International Journal of Surgical Oncology, 2012
-
Presentation of Early-Stage Non-Small Cell Lung Cancer (NSCLC) Without Radiographic Screening: End of an Era?
ASCO Annual Meeting, 2011
-
The Influence of Medical Comorbidities on the Presentation and Outcome of Stage I-III Non-Small Cell Lung Cancer
2010 ASCO Annual Meeting, 2010
-
The Association Between Clinical Characteristics, Treatment Modality and Outcomes of Non-Small Cell Lung Cancer
ASCO Annual Meeting, 2009
-
The Association Between Clinical Characteristics, Treatment Modality and Outcomes of Non-Small Cell Lung Cancer
American Society of Clinical Oncology National Meeting– Orlando, FL, 2009
-
Lung Cancer Diagnostic and Treatment Intervals in the United States: A Health Care Disparity
Journal of Thoracic Oncology, 2009
-
The Effect of a Disease Management Algorithm and Dedicated Postacute Coronary Syndrome Clinic on Achievement of Guideline Compliance: Results from the Parkland Acute Coronary Event Treatment Study
Journal of Investigative Medicine, 2008
-
The Association Between Patient Characteristics, Health Care System Characteristics and Clinical Outcomes in Non-Small Cell Lung Cancer
Eastern Cooperative Oncology Group National Meeting, 2008
-
The Effect of a Disease Management Algorithm and Dedicated Post-ACS Clinic on Achievement of Guideline Compliance: Results from the Parkland Acute Coronary Event Treatment Study
Sixth Annual University of Texas Southwestern Cardiovascular Symposium – Dallas, TX, 2006
-
Increasing Use of Evidence-Based Therapies Across Ethnic Groups After Acute Coronary Events: Observations from the Parkland Acute Coronary Event Treatment Study
Fifth Annual University of Texas Southwestern Cardiovascular Symposium – Dallas, TX, 2005